recombinant humanized anti-CD25 monoclonal antibody Clinical Trials
2 recruitingDrug
Phase 21Phase 41
Showing 1–2 of 2 trials
Recruiting
Phase 4
Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease
EBV-T/NK LPD
Beijing Children's Hospital48 enrolled1 locationNCT07029958
Recruiting
Phase 2
Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia
Transfusion Dependent Thalassemia
Rongrong Liu396 enrolled5 locationsNCT06657391